Conformational Diversity of Wild-type Tau Fibrils Specified by Templated Conformation Change*

Tauopathies are sporadic and genetic neurodegenerative diseases characterized by aggregation of the microtubule-associated protein Tau. Tau pathology occurs in over 20 phenotypically distinct neurodegenerative diseases, including Alzheimer disease and frontotemporal dementia. The molecular basis of this diversity among sporadic tauopathies is unknown, but distinct fibrillar wild-type (WT) Tau conformations could play a role. Using Fourier transform infrared spectroscopy, circular dichroism, and electron microscopy, we show that WT Tau fibrils and P301L/V337M Tau fibrils have distinct secondary structures, fragilities, and morphologies. Furthermore, P301L/V337M fibrillar seeds induce WT Tau monomer to form a novel fibrillar conformation, termed WT*, that is maintained over multiple seeding reactions. WT* has secondary structure, fragility, and morphology that are similar to P301L/V337M fibrils and distinct from WT fibrils. WT Tau is thus capable of conformational diversity that arises via templated conformation change, as has been described for amyloid β, β2-microglobulin, and prion proteins.

[1]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[2]  Jonathan S. Weissman,et al.  The physical basis of how prion conformations determine strain phenotypes , 2006, Nature.

[3]  Patrick R. Hof,et al.  Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work. , 2000, Brain Research Reviews.

[4]  F. Cohen,et al.  Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes , 2006, Proceedings of the National Academy of Sciences.

[5]  F. Cohen,et al.  Electron crystallography of the scrapie prion protein complexed with heavy metals. , 2007, Archives of biochemistry and biophysics.

[6]  G. Schellenberg,et al.  Tau is a candidate gene for chromosome 17 frontotemporal dementia , 1998, Annals of neurology.

[7]  J. Walker,et al.  Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[8]  L. Binder,et al.  Polymerization of Microtubule-associated Protein Tau under Near-physiological Conditions (*) , 1995, The Journal of Biological Chemistry.

[9]  E. Mandelkow,et al.  Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Richard D. Leapman,et al.  Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils , 2005, Science.

[11]  Mathias W. Hofmann,et al.  Secondary structure and distribution of fusogenic LV-peptides in lipid membranes , 2008, European Biophysics Journal.

[12]  R. Glockshuber,et al.  Prion Protein α-to-β Transition Monitored by Time-Resolved Fourier Transform Infrared Spectroscopy , 2007 .

[13]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[14]  R. Crowther,et al.  Abnormal tau-containing filaments in neurodegenerative diseases. , 2000, Journal of structural biology.

[15]  Satoshi Takahashi,et al.  Seeding-dependent propagation and maturation of amyloid fibril conformation. , 2005, Journal of molecular biology.

[16]  P. Lansbury,et al.  Non-genetic propagation of strain-specific properties of scrapie prion protein , 1995, Nature.

[17]  M. Goedert,et al.  Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. , 1990, The EMBO journal.

[18]  H. Naiki,et al.  Flow-induced Alignment of Amyloid Protofilaments Revealed by Linear Dichroism* , 2007, Journal of Biological Chemistry.

[19]  S. Lewis,et al.  Microtubule-associated protein MAP2 shares a microtubule binding motif with tau protein , 1988, Science.

[20]  Roger Cooke,et al.  Conformational variations in an infectious protein determine prion strain differences , 2004, Nature.

[21]  W. Kamphorst,et al.  Selective Deposition of Mutant Tau in the FTDP‐17 Brain Affected by the P301L Mutation , 2001, Journal of neuropathology and experimental neurology.

[22]  M. Hasegawa,et al.  Fibrillogenic Nuclei Composed of P301L Mutant Tau Induce Elongation of P301L Tau but Not Wild-type Tau* , 2007, Journal of Biological Chemistry.

[23]  H. Levine,et al.  Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution , 1993, Protein science : a publication of the Protein Society.

[24]  Mathias W. Hofmann,et al.  De novo design of conformationally flexible transmembrane peptides driving membrane fusion. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A Klug,et al.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.